Takayasu's arteritis (patient information): Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
|||
| Line 5: | Line 5: | ||
'''Editor-in-Chief:''' Alexandra M. Palmer | '''Editor-in-Chief:''' Alexandra M. Palmer | ||
==What is Takayasu's arteritis?== | ==What is Takayasu's arteritis?== | ||
| Line 29: | Line 29: | ||
{{Reflist}} | {{Reflist}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Patient information]] | [[Category:Patient information]] | ||
Revision as of 16:40, 20 August 2012
For the WikiDoc page for this topic, click here
Editor-in-Chief: Alexandra M. Palmer
What is Takayasu's arteritis?
Takayasu's arteritis is an inflammatory disease of unknown etiology that affects the aorta and its branches. Although it has been reported worldwide, it shows a predilection for young Asian women. Females with this disease outnumber males by 8:1, and the age of onset is typically between 15 and 30 years. In the Western world, atherosclerosis is a more frequent cause of obstruction of the aortic arch vessels than is Takayasu's arteritis.
What are the symptoms of Takayasu's arteritis?
About half of all patients develop an initial systemic illness with symptoms of malaise, fever, night sweats, weight loss, arthralgia, and fatigue. There is often an anemia and marked elevation of the ESR. This phase gradually subsides and is followed by a more chronic stage characterized by inflammatory and obliterative changes in the aorta and its branches. The other half of patients with Takayasu's arteritis present with only late vascular changes, without an antecedent systemic illness. In the late stage, weakness of the arterial walls may give rise to localized aneurysms.
Four types of late-phase Takayasu arteritis are described on the basis of the sites of involvement as follows:[1]
- Type I - Classic pulseless type that involves the brachiocephalic trunk, carotid arteries, and subclavian arteries
- Type II - Combination of type I and III
- Type III - Atypical coarctation type that involves the thoracic and abdominal aortas distal to the arch and its major branches
- Type IV - Dilated type that involves extensive dilatation of the length of the aorta and its major branches
Treatment
The great majority of patients with Takayasu’s arteritis respond to prednisone. The usual starting dose is approximately 1 milligram per kilogram of body weight per day (for most people, this is approximately 60 milligrams a day). Because of the significant side effects of long-term high–dose prednisone use, the starting dose is tapered over several weeks to a dose that the physician feels is tolerable for the patient.
Where to find medical care for Takayasu's arteritis
Directions to Hospitals Treating Takayasu's arteritis
Sources
- ↑ "eMedicine - Arteritis, Takayasu : Article by Robert L Cirillo, Jr, MD, MBA". Retrieved 2007-07-19.